THOUGHT OF THE WEEK
FOUR REASONS TO INVEST NOW (PART 1)

After growing your emergency fund, which you can rely on in times of emergency, you have enough money and time to grow your investments uninterrupted, which offers a high growth potential and a faster way of meeting your financial goals

1. Enjoy the benefits of compound interest
“Compound interest is the eighth wonder of the world. He, who understands it, earns it and he who doesn’t pays it.” This is a quote by Albert Einstein. When you understand how compound interest can grow your investments, it becomes easier to make the decision of starting investment now.
Assuming you invest GHS 1,000 in year 1 at an interest of 15%, at the end of year 1 your investment will be worth GHS 1,150. In year 2, your GHS 1,150 investment will grow to GHS 1,322.50 In year 3, your GHS 1,322.50 investment will grow to GHS 1,520.87
In year 4, your GHS 1,520.87 investment will grow to GHS 1,749.01
By the end of year 5, your original investment of GHS 1,000 will be worth GHS 2,011.36
This illustration demonstrates the beauty of compounding on your investments. What it simply means is that, your money is making more money and each interest earned on the investment is added to the original balance and continues to grow…. (To be
continued)

Disclaimer
This weekly report is the copyright of NIMED Capital Ltd. (NIMED), an investment banking company licensed and regulated by the Securities and Exchange Commission (S.E.C.) of Ghana as Investment Advisers as well as the National Pensions Regulatory Authority (N.P.R.A.) as an approved Pension Fund Manager. Information and opinions herein have been compiled or arrived at based on information obtained from sources considered reliable; we therefore do not hold ourselves responsible for its completeness or accuracy. All statements of opinion, projections, forecasts, or those relating to expectations regarding future events or performance of investments represent NIMED’s own assessment and interpretation of information currently available to NIMED, which are subject to change.